Şunu aradınız:: paralelnimi (Slovence - İngilizce)

obe študiji sta bili dvojno slepi, randomizirani in s paralelnimi skupinami.
both were of double- blind, randomised, parallel-group type.

diabetesom tipa 1 in tipa 2 so opravili randomizirane odprte študije s paralelnimi skupinami.
a decline from baseline in fev1 of > 15% occurred in 1.3% of exubera-treated and 1.0% of pr

umerjanje je treba izvajati s paralelnimi meritvami k referenčnim metodam najmanj vsaka tri leta.
calibration must be carried out by means of parallel measurements with the reference methods at least every three years.

bela, z rjavkasto prevleko, ovalna tableta dolžine 17 mm s tremi paralelnimi zarezami.
white, with a slight brownish mottling, oval tablet of 17 mm length with three parallel break-lines.

pri preiskovancih z asimptomatskim hae so opravili randomizirano odprto farmakokinetično študijo zdravila cinryze s paralelnimi skupinami.
a randomised, parallel group, open-label pharmacokinetic study of cinryze was performed in subjects with non-symptomatic hae.

opravljeni sta bili dve dvojno slepi študiji s paralelnimi skupinami naključno izbranih bolnikov, ki so predhodno že jemali antikoagulacijska zdravila.
two randomized, parallel group, double-blind studies were performed in patients previously treated with anticagulation therapy.

za raziskovanje sprememb fev1 po uvedbi zdravljenja z zdravilom exubera pri bolnikih z diabetesom tipa 1 in tipa 2 so opravili randomizirane odprte študije s paralelnimi skupinami.
randomised, open label parallel group studies were conducted to examine fev1 changes following uc

učinkovitost in varnost degareliksa so ovrednotili v odprti, multicentrični, randomizirani študiji s paralelnimi skupinami, kontrolirani z aktivnim primerjalnim zdravilom.
the efficacy and safety of degarelix was evaluated in an open-label, multi-centre, randomised, active comparator controlled, parallel-group study.

rezultati potrditvene študije faze iii učinkovitost in varnost degareliksa so ovrednotili v odprti, multicentrični, randomizirani študiji s paralelnimi skupinami, kontrolirani z aktivnim primerjalnim zdravilom.
results of the confirmatory phase iii study the efficacy and safety of degarelix was evaluated in an open-label, multi-centre, randomised, active comparator controlled, parallel-group study.

učinkovitost in varnost so proučili v dveh multicentričnih, dvojno slepih, replikacijskih študijah s paralelnimi skupinami naključno izbranih bolnikov, re-cover in re-cover ii.
the efficacy and safety was investigated in two multi-center, randomised, double blind, parallel- group, replicate studies re-cover and re-cover ii.

več kakor eno podatkovno ali ukazno vodilo ali zaporedna komunikacijska vrata za zunanjo medsebojno povezavo med paralelnimi "mikroprocesorskimi mikrovezji" s stopnjo prenosa več kakor 150 mbajtov/s;
more than one data or instruction bus or serial communication port that provides a direct external interconnection between parallel "microprocessor microcircuits" with a transfer rate exceeding 150 mbyte/s;

rezultati randomizirane, odprte, multicentrične študije ifm 99- 06 iii. faze s paralelnimi skupinami so pokazali prednost preživetja pri uporabi talidomida v kombinaciji z melfalanom in prednizonom za 12 ciklov po 6 tednov pri zdravljenju bolnikov z na novo diagnosticiranim multiplim mielomom.
in